What is Charcot-Marie-Tooth Disease

Charcot-Marie-Tooth disease (CMT) is a group of inherited neurological disorders that damage the peripheral nerves, leading to progressive muscle weakness, atrophy, and loss of sensation, most commonly in the feet and lower legs. While it is a chronic, life-long condition, it is typically not fatal, and individuals with Charcot-Marie-Tooth disease often maintain a normal life expectancy with appropriate symptom management.

What body systems are affected by Charcot-Marie-Tooth disease?

Charcot-Marie-Tooth disease primarily affects the peripheral nervous system, which acts as the communication network between the brain and the rest of the body. Because the nerves controlling the muscles and transmitting sensory information are damaged, the disease impacts both the muscular system and the skeletal system. Patients frequently experience foot drop, balance issues, and muscle wasting. In some advanced cases, the nerves controlling the throat may be affected, leading to swallowing difficulties, though this is less common than the limb-related symptoms.

How common is Charcot-Marie-Tooth disease and who does it affect?

Charcot-Marie-Tooth disease is considered one of the most common inherited neurological disorders. It affects approximately 1 in 2,500 people worldwide, meaning roughly 126,000 people in the United States alone are living with some form of the condition. There is no significant gender or geographic bias; it affects men and women of all ethnic backgrounds equally. Onset typically occurs in adolescence or early adulthood, though symptoms can sometimes manifest in early childhood or not until middle age.

What are the primary subtypes of Charcot-Marie-Tooth disease?

The condition is genetically heterogeneous, meaning it is caused by mutations in many different genes. Researchers categorize Charcot-Marie-Tooth disease into several main types based on how the nerves are damaged:

• CMT1: Involves the breakdown of the myelin sheath (the insulation around nerves), which slows down nerve signal conduction.


• CMT2: Involves primary damage to the axon (the nerve fiber itself), leading to a reduction in the strength of signals sent to muscles.


• CMT3 (Dejerine-Sottas disease): A rarer, more severe form that often presents in infancy.


• CMT4: A group of autosomal recessive forms that can present with more severe symptoms.


• CMTX: An X-linked form where the gene mutation is located on the X chromosome.

What differentiates Charcot-Marie-Tooth disease from other conditions?

Unlike conditions that cause generalized weakness, Charcot-Marie-Tooth disease is specifically characterized by a "distal" pattern of symptoms, meaning problems start at the furthest points of the body (feet and hands) and move inward. While patients often report chronic pain, burning sensations, and extreme fatigue, the disease is distinct from primary muscle diseases (myopathies) because the root cause is nerve degeneration rather than intrinsic muscle damage. Currently, 1,193 members of the DiseaseMaps community have joined to share their specific experiences with these symptoms.

Next steps

• Consult a clinical neurophysiologist or neurologist to confirm your diagnosis through nerve conduction studies or genetic testing.


• Work with a physical therapist to develop a routine focused on maintaining muscle strength and preventing contractures.


• Consult a podiatrist or orthopaedic specialist regarding custom orthotics or bracing to manage foot drop and improve balance.


• Connect with the DiseaseMaps community to share experiences with others living with the condition.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always seek the guidance of your physician regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Charcot-Marie-Tooth disease.


• Orphanet: Rare disease database entry for Charcot-Marie-Tooth disease.


• OMIM (Online Mendelian Inheritance in Man): Comprehensive catalog of human genes and genetic disorders.


• Charcot-Marie-Tooth Association (CMTA): Patient-focused clinical and research information.